🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 5 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/05/1997 | 44,45 | 44,92 | 43,51 | 43,98 | -2,08% | 3,16% | 40.609 |
| 21/05/1997 | 44,92 | 44,92 | 43,98 | 44,92 | +1,05% | 2,08% | 28.934 |
| 20/05/1997 | 44,45 | 44,45 | 43,04 | 44,45 | +0,00% | 3,16% | 26.530 |
| 19/05/1997 | 44,45 | 44,45 | 43,51 | 44,45 | +0,00% | 2,11% | 98.104 |
| 16/05/1997 | 43,04 | 44,45 | 42,58 | 44,45 | +3,26% | 4,35% | 107.615 |
| 15/05/1997 | 45,85 | 45,85 | 42,34 | 43,04 | -4,17% | 7,65% | 85.707 |
| 14/05/1997 | 45,85 | 46,32 | 44,92 | 44,92 | +0,00% | 3,06% | 110.099 |
| 13/05/1997 | 44,92 | 45,85 | 44,45 | 44,92 | +1,05% | 3,12% | 103.447 |
| 12/05/1997 | 44,45 | 44,45 | 43,51 | 44,45 | +4,40% | 2,11% | 28.079 |
| 09/05/1997 | 43,51 | 43,51 | 42,11 | 42,58 | +0,00% | 3,23% | 14.935 |
| 08/05/1997 | 44,45 | 44,92 | 42,58 | 42,58 | -5,21% | 5,26% | 42.667 |
| 07/05/1997 | 44,92 | 44,92 | 43,04 | 44,92 | +0,00% | 4,17% | 34.972 |
| 06/05/1997 | 44,45 | 46,32 | 43,51 | 44,92 | +1,05% | 6,32% | 100.562 |
| 05/05/1997 | 39,77 | 44,45 | 39,77 | 44,45 | +13,10% | 11,76% | 65.750 |
| 02/05/1997 | 38,83 | 41,17 | 38,37 | 39,30 | +1,20% | 7,23% | 54.983 |
| 01/05/1997 | 38,83 | 39,30 | 37,43 | 38,83 | +1,22% | 4,82% | 26.503 |
| 30/04/1997 | 38,37 | 38,83 | 37,43 | 38,37 | -1,20% | 3,66% | 36.842 |
| 29/04/1997 | 39,30 | 39,77 | 37,43 | 38,83 | -1,19% | 5,95% | 29.014 |
| 28/04/1997 | 38,37 | 41,17 | 37,90 | 39,30 | +3,70% | 8,54% | 39.888 |
| 25/04/1997 | 35,09 | 38,37 | 35,09 | 37,90 | +6,58% | 9,33% | 30.190 |
| 24/04/1997 | 35,09 | 36,03 | 34,62 | 35,56 | +2,70% | 4,00% | 38.499 |
| 23/04/1997 | 34,15 | 35,09 | 34,15 | 34,62 | +1,37% | 2,74% | 26.556 |
| 22/04/1997 | 35,56 | 36,03 | 34,15 | 34,15 | -2,67% | 5,26% | 77.131 |
| 21/04/1997 | 36,03 | 36,03 | 34,62 | 35,09 | -1,32% | 3,90% | 28.907 |
| 18/04/1997 | 36,03 | 36,96 | 35,09 | 35,56 | -2,56% | 5,19% | 29.549 |
| 17/04/1997 | 38,37 | 38,83 | 36,49 | 36,49 | -4,88% | 6,10% | 41.571 |
| 16/04/1997 | 38,37 | 38,83 | 37,90 | 38,37 | +0,00% | 2,44% | 26.262 |
| 15/04/1997 | 37,43 | 39,30 | 37,43 | 38,37 | +3,80% | 5,00% | 74.887 |
| 14/04/1997 | 37,43 | 37,90 | 36,49 | 36,96 | -1,25% | 3,75% | 32.995 |
| 11/04/1997 | 37,90 | 38,37 | 37,20 | 37,43 | -2,44% | 3,09% | 81.646 |